openPR Logo
Press release

Antacids Tablets Market Future Outlook, COVID-19 Impact Analysis, Forecast - 2031

12-13-2024 03:36 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Antacids Tablets Market

Antacids Tablets Market

The global antacids tablets market is expected to grow at a significant CAGR during the forecast period (2024-2031). Antacids are over-the-counter medications that are used to relieve heartburn, stomach pain, acid reflux, and stomach distress. It protects the stomach, duodenum, and esophagus from harsh acids created during food digestion. The availability of a variety of chewable tablets in a number of tastes that aid in patient adherence to medication is projected to drive global antacid tablet market growth. As the tablets are the low-cost oral dose form and are easy to handle, use, and carry, they are the most extensively utilized solid dosage form.

Get Free Sample link @ https://www.omrglobal.com/request-sample/antacids-tablets-market

Furthermore, the market is predicted to rise due to the growing geriatric population, which is more susceptible to gastrointestinal problems. Acidic problems are common in the older population, making it a unique challenge for both the primary care physician and the gastroenterologist. Furthermore, such patients are more likely to have a number of symptomatic illnesses, such as erosive esophagitis, Barrett's esophagus, and esophageal cancer, which require a combination of medications to cure, and the usage of antacids is substantially higher in these cases. According to the 2019 revision of the World Population Prospects, by 2050, one in every six people in the world will be over the age of 65 (16%), up from one in every eleven people in 2019.

The key companies operating in the global antacid tablet market are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches, to remain competitive in the marketplace. For instance, in January 2019, Dr. Reddy's laboratories introduced generic omeprazole delayed-release tablets for the treatment of heartburn in the US. In April 2018, Perrigo also released a new orally disintegrating omeprazole tablet for the treatment of persistent heartburn. In October 2020, Dr. Reddy's laboratories re-launched Famotidine Tablets USP, 10 mg and 20 mg, over-the-counter (OTC) in the US market. In March 2020, Lupin released an authorized generic for Horizon Therapeutics PLC's Vimovo (naproxen/esomeprazole magnesium) delayed-release tablets in the US. The drug is a mixture of naproxen and esomeprazole magnesium, with naproxen being used for symptomatic treatment of arthritis and esomeprazole magnesium being used to reduce the risk of naproxen-associated stomach ulcers.

Full report of Antacids Tablets Market available @ https://www.omrglobal.com/industry-reports/antacids-tablets-market

Market Coverage

Segment Covered-

By Distribution Channel

Regions covered-

North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape: Johnson and Johnson Services, Inc., GlaxoSmithKline plc, and Sanofi S.A., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Antacids Tablets Market Report by Segment

By Distribution Channel

Online
Offline

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antacids-tablets-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacids Tablets Market Future Outlook, COVID-19 Impact Analysis, Forecast - 2031 here

News-ID: 3787338 • Views:

More Releases from Orion Market Research

Sports Gun Market: Emerging Trends and Growth Forecast to 2032
Sports Gun Market: Emerging Trends and Growth Forecast to 2032
The global sports gun market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 3.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032. Sports Gun Market Overview The sports gun market encompasses firearms designed for competitive shooting, hunting, and recreational activities. Factors contributing to market growth include the rising popularity of shooting sports, technological advancements
Trade Finance Market Overview: Growth, Share, Value, Size, and Scope
Trade Finance Market Overview: Growth, Share, Value, Size, and Scope
The global trade finance market was valued at approximately $10.52 trillion in 2023 and is projected to reach around $13.66 trillion by 2032, exhibiting a compound annual growth rate (CAGR) of nearly 2.94% from 2024 to 2032. Trade Finance Market Overview Trade finance encompasses financial instruments and products that facilitate international trade and commerce, including letters of credit, guarantees, and insurance. The market's growth is driven by the increasing globalization
Small Molecule Cancer Drug Market: An In-Depth Analysis
Small Molecule Cancer Drug Market: An In-Depth Analysis
The global small molecule cancer drug market was valued at approximately $83.20 billion in 2023 and is projected to reach around $139.37 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.90% from 2024 to 2032. Small Molecule Cancer Drug Market Overview Small molecule cancer drugs are low molecular weight compounds that can easily enter cells to modulate specific biological processes, making them effective in cancer treatment. The
Small Boat Market: A Comprehensive Overview
Small Boat Market: A Comprehensive Overview
The global Small Boat market was valued at approximately $1.8 billion in 2023 and is projected to reach around $4.3 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.3% from 2024 to 2032. Small Boat Market Overview Small Boat encompasses digital tools designed to enhance the diagnosis, treatment, and management of neurological disorders. The market's growth is driven by the increasing prevalence of neurological conditions, rising demand

All 5 Releases


More Releases for Antacids

Antacids Market Analysis by Key Players & Industry Size 2027
Allied Market Research published a report, titled, “Antacids Market: Global Opportunity Analysis and Industry Forecast 2019–2027". According to the report, the Global Antacids industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10646 Major players analyzed include GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC, Boehringer
03-15-2021 | Health & Medicine
Fact.MR
Antacids Market to soar with CAGR of ~4% by 2025
Online pharmacies will grow as a prominent sales channel in the antacids market. A marked rise in the popularity of this channel is attributable to consumer-centric deals, such as attractive discounts and home delivery services. There is no permanent panacea for acid reflux and heartburn, which inadvertently is expected to retain consumers’ reliance on antacids. This Press Release will help you to understand the market Statistics of European Region. Click HERE To
Antacids Market Companies Overview 2017 - 2025
The global antacids market features a large number of companies, both international as well as regional, which serve the global market through a large number of products varieties and brands. The level of competition is thus intense and the high focus of companies on new markets and growth opportunities is evident through the several strategic collaborations to have taken place in the market in the past years, observes Transparency Market
Antacids Market Overview and Industry Outlook 2020
Global Antacids Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Antacids Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Antacids Market will Clock a 3.7% CAGR Between 2017 and 2025
The worldwide antacids market is a choc-o-bloc with large companies that hold prominence due to their product offerings and presence across geographies, observes Transparency Market Research (TMR). R&D initiatives for the introduction of novel therapies, improving efficacy of existing drugs are the focus of key players in this market to gain competitive advantage. These players are also seeking strategic partnerships and business alliances to strengthen their research expertise as well
Global Antacids Market to Surpass US$18.7 bn by 2025
With a large pool of established players such as AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Reckitt Benckiser Group plc, Sanofi, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Ltd., and Valeant Pharmaceuticals International Inc., the worldwide antacids market features a competitive and a fragmented vendor landscape, notes a research report by Transparency Market Research (TMR). Development of novel therapies